A prospective study evaluating surgery and chemo radiation in muscle invasive bladder cancer

Journal of Cancer Research and Therapeutics

Volumn 3, Issue 2, 2007, Pages 81-85

  Haresh, K P ^a   Julka, P K ^a   Sharma, D N ^a   Rath, G K ^a   Prabhakar, R ^a   Seth, A ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Chemo radiation; Muscle invasive bladder cancer; Radical cystectomy

Indexed keywords

CISPLATIN; METHOTREXATE; VINBLASTINE;

ABDOMINAL INJURY; ANURIA; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTESTINE OBSTRUCTION; KIDNEY FAILURE; MALE; METABOLIC ACIDOSIS; MULTIPLE CYCLE TREATMENT; MUSCLE CANCER; NEUTROPENIA; PERITONITIS; POSTOPERATIVE COMPLICATION; RESPIRATORY FAILURE; SEPTICEMIA; TRANSITIONAL CELL CARCINOMA; URINE INCONTINENCE;

EID: 34548687963     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.34684     Document Type: Article

References (22)

1. th ed, ch. 51. 2001. p. 828-45.
2. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, et al. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991;145:45-50.
3. Greven KM, Spera JA, Solin LJ, Morgan T, Hanks GE. Local recurrence after cystectomy alone for bladder Carcinoma. Cancer 1992;69:2767-70.
4. Freiha F, Reese J, Torti FM. Randomized trial of radical cystectomy versus radical cystectomy plus CMV chemotherapy for muscle incase bladder cancer. J Urol 1996;155:495-500.
5. Tester W, Caplan R, Heaney J, Venner P, Whittington R, Byhardt R, et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: Results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol 1996;14:119-26.
6. Housset M, Maulard C, Chretien Y, Dufour B, Delanian S, Huart J, et al. Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder: A prospective study. J Clin Oncol 1993;11:2150-7.
7. Kim HL, Steinberg GD. The current status of bladder preservation in the treatment of muscle invasive bladder cancer. J Urol 2000;164:627-32.
8. Dunst J, Sauer R, Schrott KM, Kuhn R, Wittekind C, Altendorf-Hofmann A. Organ sparing treatment of advanced bladder cancer: A 10 year experience. Int J Radiat Oncol Biol Phys 1994;30:261-6.
9. Rolf S. Efficacy of radio chemotherapy using platinum derivatives compared to radiotherapy alone in organ sparing treatment of bladder cancer. IJROBP 1998;:40.
10. Dimopoulos MA, Moulopoulos LA. Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder. J Clin Oncol 1998;16:1601-12.
11. Adjuvant chemotherapy for muscle invasive bladder cancer. Cochrane Database Syst Rev 2006;2:CD006018.
12. Roberts JT, Fossa SD, Richards B, Kaye SB, White EF, Robinson MC, et al. Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder. Br J Urol 1991;68:162-8.
13. Shipley WU, Winter KA, Kaufman DS, Lee WR, Heney NM, Tester WR, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 1998;16:3576-83.
14. Logothetis C, Swanson D, Amato R, Banks M, Finn L, Ayala A, et al. Optimal delivery of perioperative chemotherapy: Preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma. J Urol 1996;155:1241-5.
15. Sternberg CN. MVAC for advanced TCC of urothelium. J Urol 1988;135:461-9.
16. Skinner DG, Lieskovsky G. Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J urol 1984;131: 1069-72.
17. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, et al. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991;145:45-50.
18. Fosså SD, Waehre H, Aass N, Jacobsen AB, Olsen DR, Ous S. Bladder cancer definitive radiation therapy of muscle invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 1993;72:3036-43.
19. Gospodarowicz MK, Hawkins NV, Rawlings GA, Connolly JG, Jewett M, Thomas GM, et al. Radical radiotherapy for muscle invasive TCC of the bladder: Failure analysis. J Urol 1989;142:1448-54.
20. Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL, et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 1997;15:1022-9.
21. Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H. Rapidly alternative chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle invasive cancer of urinary bladder. Cancer 1998;82:5.
22. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005;48:202-5.